Detecting neurodegenerative diseases Alzheimer’s disease and other neurodegenerative diseases undergo a multiple decade long process on a molecular level before their first clinical symptoms arise. In fact, 15-20 years before any clinical symptoms, molecular changes can be observed in the brain through the misfolding of protein biomarkers. With betaSENSE’s platform technology, we can precisely monitor and quantify this process in body fluids